Almotriptan

Details

Files

Generic Name:

Almotriptan

Project Status:

Complete

Therapeutic Area:

Migraine

Manufacturer:

Janssen-Ortho Inc.

Brand Name:

Axert

Project Line:

Reimbursement Review

Project Number:

SR0005-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Migraine

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

May 27, 2004

Recommendation:

List in a similar manner as drug plans list other triptans currently approved in Canada.

Last Updated : December 24, 2003